Citadel Advisors »

Curanex Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Curanex Pharmaceuticals (CURX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Curanex Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Curanex Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Curanex Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $26k 51k 0.51
2025-12-31 $35k 104k 0.33
2025-09-30 $46k 64k 0.72

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Curanex Pharmaceuticals

Geode Capital Management
Renaissance Technologies
Two Sigma Securities
Citadel Advisors
XTX Topco
Two Sigma Investments
Citigroup
Jump Financial
UBS Group

View all funds holding Curanex Pharmaceuticals